Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army
McKinsey
Accenture
Fuji
Harvard Business School
Healthtrust
Moodys
Boehringer Ingelheim

Generated: May 21, 2018

DrugPatentWatch Database Preview

SELEGILINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Selegiline Hydrochloride patents expire, and what generic alternatives are available?

Selegiline Hydrochloride is a drug marketed by Apotex, Dava Pharms Inc, Lannett Co Inc, Apotex Inc, Boscogen, Chartwell Molecules, G And W Labs Inc, Mylan, Siegfried, and Somerset. and is included in thirteen NDAs.

The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
Drug patent expirations by year for SELEGILINE HYDROCHLORIDE
Synonyms for SELEGILINE HYDROCHLORIDE
(-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine hydrochloride
(-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine monohydrochloride
(-)-Deprenil hydrochloride
(-)-Deprenyl hydrochloride
(-)-E-250 hydrochloride
(-)-N,alpha-Dimethyl-N-2-propynylbenzeneethanamine hydrochloride
(-)-Phenylisopropylmethylpropynylamine
(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine hydrochloride
(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine;hydrochloride
(R)-(-)-Deprenyl hydrochloride
(R)-(-)-N-?-Dimethyl-N-2-propynylbenzeneethanamine hydrochloride
(R)-(-)-N,alpha-Dimethyl-N-(2-propynyl)phenethylamine hydrochloride
(R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride
(R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-aminehydrochloride
14611-51-9 (Parent)
14611-52-0
40602-63-9
611S520
6W731X367Q
AC-18759
AC1L1BU2
AK115813
AKOS005166822
Ambap14611-52-0
API0004151
AX8151001
Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, hydrochloride, (R)-
BG0405
Bio-0098
C13H17N.HCl
CAS-14611-52-0
CC-34395
CCG-100773
CCRIS 8571
CHEBI:9087
CHEMBL1200904
CPD000449328
CS-2764
D00785
D0J2MJ
D0OH5I
D0Y8AN
DSSTox_CID_24584
DSSTox_GSID_44584
DSSTox_RID_80331
DTXSID9044584
E-250
Eldepryl
Eldepryl (TN)
Eldepryl hydrochloride
Ensam
FPF-1100
FPF1100
FT-0601539
HMS1569P05
HSDB 7183
HY-14199
IYETZZCWLLUHIJ-UTONKHPSSA-N
Jumex hydrochloride
K-4669
KS-00000059
KS-5098
L-Deprenyl
l-Deprenyl hydrochloride
LS-30157
MFCD00069299
MLS000758294
MLS001423947
MLS002153281
MLS002222269
NC00023
NC00605
NCGC00016708-01
NCGC00024994-06
NCGC00255797-01
Otrasel
Plurimen
Prestwick_846
R-(-)-Deprenyl (hydrochloride)
R-(-)-Deprenyl hydrochloride
R-(-)-Deprenyl hydrochloride, powder, >=98% (HPLC)
R-(-)deprenyl hydrochloride
SAM001246969
SAM002589926
SCHEMBL41392
Seledat
Selegiline Hcl
Selegiline hydrochloride (JAN/USP)
Selegiline hydrochloride [USAN:USP]
Selegiline hydrochloride [USAN]
Selegiline Hydrochloride 1.0 mg/ml in Methanol (as free base)
Selegiline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Selegiline hydrochloride, United States Pharmacopeia (USP) Reference Standard
SMR000449328
SR-01000597928
SR-01000597928-5
ST24035592
Tox21_110572
Tox21_110572_1
Tox21_301846
UNII-63G7R4955A component IYETZZCWLLUHIJ-UTONKHPSSA-N
UNII-6W731X367Q
Vivapryl
Xilopar
Zelapar
Zydis selegiline

US Patents and Regulatory Information for SELEGILINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075321-001 Dec 4, 1998 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Chartwell Molecules SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074641-001 Aug 2, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex Inc SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074871-001 Jun 6, 1997 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Siegfried SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074672-001 Apr 1, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Accenture
AstraZeneca
Fish and Richardson
US Army
Chubb
QuintilesIMS
Cerilliant
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.